| 1 |
35457111 | The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines. | 2022 Apr 13 |
1 |
| 2 |
33637776 | BKM120 sensitizes BRCA-proficient triple negative breast cancer cells to olaparib through regulating FOXM1 and Exo1 expression. | 2021 Feb 26 |
2 |
| 3 |
33753551 | AP-2α Regulates S-Phase and Is a Marker for Sensitivity to PI3K Inhibitor Buparlisib in Colon Cancer. | 2021 Jul |
1 |
| 4 |
34649154 | Development of anti-breast cancer PI3K inhibitors based on 7-azaindole derivatives through scaffold hopping: Design, synthesis and in vitro biological evaluation. | 2021 Dec |
1 |
| 5 |
32898555 | Buparlisib modulates PD-L1 expression in head and neck squamous cell carcinoma cell lines. | 2020 Nov 1 |
1 |
| 6 |
33371187 | Proteomic Resistance Biomarkers for PI3K Inhibitor in Triple Negative Breast Cancer Patient-Derived Xenograft Models. | 2020 Dec 21 |
1 |
| 7 |
30982255 | [NVP-BKM120 in combination with letrozole inhibit human breast cancer stem cells via PI3K/mTOR pathway]. | 2019 Apr 9 |
2 |
| 8 |
29430197 | Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date. | 2018 |
1 |
| 9 |
27507562 | Combination of phosphotidylinositol-3-kinase targeting with cetuximab and irradiation: A preclinical study on an orthotopic xenograft model of head and neck cancer. | 2017 Jan |
1 |
| 10 |
28662162 | BKM120 induces apoptosis and inhibits tumor growth in medulloblastoma. | 2017 |
1 |
| 11 |
29024814 | Anti-tumor effects of NVP-BKM120 alone or in combination with MEK162 in biliary tract cancer. | 2017 Dec 28 |
1 |
| 12 |
29151909 | BKM120 sensitizes C6 glioma cells to temozolomide via suppression of the PI3K/Akt/NF-κB/MGMT signaling pathway. | 2017 Dec |
2 |
| 13 |
27121230 | Combined use of PI3K and MEK inhibitors synergistically inhibits lung cancer with EGFR and KRAS mutations. | 2016 Jul |
1 |
| 14 |
27307593 | PI3K Pathway Inhibition Achieves Potent Antitumor Activity in Melanoma Brain Metastases In Vitro and In Vivo. | 2016 Dec 1 |
2 |
| 15 |
27572309 | Blockade efficacy of MEK/ERK-dependent autophagy enhances PI3K/Akt inhibitor NVP-BKM120's therapeutic effectiveness in lung cancer cells. | 2016 Oct 11 |
1 |
| 16 |
25937299 | Enhancing therapeutic efficacy of the MEK inhibitor, MEK162, by blocking autophagy or inhibiting PI3K/Akt signaling in human lung cancer cells. | 2015 Aug 1 |
2 |
| 17 |
26044191 | NVP-BKM120 potentiates apoptosis in tumor necrosis factor-related apoptosis-inducing ligand-resistant glioma cell lines via upregulation of Noxa and death receptor 5. | 2015 Aug |
2 |
| 18 |
26256696 | Comparative effect of two pan-class I PI3K inhibitors used as anticancer drugs on human T cell function. | 2015 Sep |
1 |
| 19 |
26402468 | Evaluation of In Vitro Activity of the Class I PI3K Inhibitor Buparlisib (BKM120) in Pediatric Bone and Soft Tissue Sarcomas. | 2015 |
1 |
| 20 |
26673665 | Effects of PI3K inhibitor NVP-BKM120 on overcoming drug resistance and eliminating cancer stem cells in human breast cancer cells. | 2015 Dec 17 |
2 |
| 21 |
24310736 | Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia. | 2014 Jun |
1 |
| 22 |
24741074 | Inhibition of phosphatidylinositol 3-kinase/AKT signaling by NVP-BKM120 promotes ABT-737-induced toxicity in a caspase-dependent manner through mitochondrial dysfunction and DNA damage response in established and primary cultured glioblastoma cells. | 2014 Jul |
2 |
| 23 |
23238639 | The phosphatidylinositol-3 kinase I inhibitor BKM120 induces cell death in B-chronic lymphocytic leukemia cells in vitro. | 2013 Jul |
1 |
| 24 |
23850807 | The phosphatidylinositol-3-kinase inhibitor NVP-BKM120 overcomes resistance signals derived from microenvironment by regulating the Akt/FoxO3a/Bim axis in chronic lymphocytic leukemia cells. | 2013 Nov |
4 |
| 25 |
24337846 | Effects of PI3K inhibitor NVP-BKM120 on acquired resistance to gefitinib of human lung adenocarcinoma H1975 cells. | 2013 Dec |
2 |
| 26 |
22159814 | NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations. | 2012 Apr |
1 |